Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria-Reference-Cited by-同舟云学术

Dilipid Ultrashort Tetrabasic Peptidomimetics Potentiate Novobiocin and Rifampicin Against Multidrug-Resistant Gram-Negative Bacteria

Published:2020-05-01 Issue:6 Volume:6 Page:1413-1426
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Ramirez Danyel¹,Berry Liam¹,Domalaon Ronald¹,Brizuela Marc¹,Schweizer Frank¹²^ORCID

Affiliation:

1. Department of Chemistry, Faculty of Science, University of Manitoba, 144 Dysart Road, Winnipeg, Manitoba R3T 2N2, Canada

2. Department of Medical Microbiology and Infectious Diseases, Rady Faculty of Health Sciences, University of Manitoba, 727 McDermot Avenue, Winnipeg, Manitoba R3T 1R9, Canada

Funder

Institute of Infection and Immunity

Natural Sciences and Engineering Research Council of Canada

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.0c00017

Reference41 articles.

1. Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux

2. O’Neill, J. (2016) Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Review on Antimicrobial Resistance, HM Government and the Wellcome Trust, London, available online at https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf.

3. Antimicrobial peptides

4. Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents

5. Antimicrobial Peptides: the Achilles’ Heel of Antibiotic Resistance?

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic adjuvants against multidrug-resistant Gram-negative bacteria: important component of future antimicrobial therapy;Microbiological Research;2024-10

2. Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens;Exploration of Drug Science;2024-04-29

3. New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis;Antibiotics;2024-01-11

4. Amphiphilic tribasic galactosamines potentiate rifampicin in Gram-negative bacteria at low Mg++/Ca++concentrations;Bioorganic & Medicinal Chemistry Letters;2024-01

5. Famotidine Enhances Rifampicin Activity against Acinetobacter baumannii by Affecting OmpA;Journal of Bacteriology;2023-08-24